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Despite increasing evidence suggesting a role for NADPH oxidases (Nox) in bone pathophysiology, whether Nox enzymes
contribute to obesity-mediated bone remodeling remains to be clearly elucidated. Nox2 is one of the predominant Nox enzymes
expressed in the bone marrow microenvironment and is a major source of ROS generation during inﬂammatory processes. It is
also well recognized that a high-fat diet (HFD) induces obesity, which negatively impacts bone remodeling. In this work, we
investigated the eﬀect of Nox2 loss of function on obesity-mediated alteration of bone remodeling using wild-type (WT) and
Nox2-knockout (KO) mice fed with a standard lab chow diet (SD) as a control or a HFD as an obesity model. Bone mineral
density (BMD) of mice was assessed at the beginning and after 3 months of feeding with SD or HFD. Our results show that
HFD increased bone mineral density to a greater extent in KO mice than in WT mice without aﬀecting the total body weight
and fat mass. HFD also signiﬁcantly increased the number of adipocytes in the bone marrow microenvironment of WT mice as
compared to KO mice. The bone levels of proinﬂammatory cytokines and proosteoclastogenic factors were also signiﬁcantly
elevated in WT-HFD mice as compared to KO-HFD mice. Furthermore, the in vitro diﬀerentiation of bone marrow cells into
osteoclasts was signiﬁcantly increased when using bone marrow cells from WT-HFD mice as compared to KO-HFD mice. Our
data collectively suggest that Nox2 is implicated in HFD-induced deleterious bone remodeling by enhancing bone marrow
adipogenesis and osteoclastogenesis.

1. Introduction
Obesity is deﬁned as a body mass index (BMI) greater than or
equal to 30. The obesity epidemic correlates with increasing
evidence that lipotoxicity and inﬂammation might be the
cause of bone loss [1–3]. Studies in mice and humans
indicate that obesity is related to a sustained and elevated
inﬂammatory state of adipose tissue [3, 4]. Several molecular
and cellular determinants involved in inﬂammation- and
lipotoxicity-induced bone mass loss have been suggested

[1, 5]. Obesity is associated with enhanced tissue inﬂammation [6]. More recently, it has been shown that a fat increase
in the bone marrow (BM) microenvironment [7] may aﬀect
bone homeostasis, by inhibiting osteoblast function and
increasing osteoclast diﬀerentiation/activation [8], through
the regulation of inﬂammatory cytokines [9]. Nevertheless,
data concerning the impact of obesity on bone health are still
controversial. Indeed, the augmented body mass due to obesity may increase mechanical bone stretching improving both
bone mass and mineral density, while increased adiposity in
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the bone marrow region can lower osteoblast/osteocyte
formation, generating low-quality bone and enhanced risk
of fracture. However, some studies showed that obesity
reduces fracture risk and protects against osteoporosis in
adults [10, 11], while others showed that obesity does not
protect against fracture in postmenopausal women [12, 13].
Interestingly, one study reported that obesity is a risk factor
for fracture in children, while it is protective against fracture
in adults [14], suggesting that the eﬀects of obesity on bone
parameters may diﬀer with age.
Akin to obesity, a high-fat diet (HFD) can inﬂuence the
bone microenvironment and remodeling. For instance,
decreases in both bone resorption and formation have been
reported in HFD-fed mice [15], while increased bone mineral
density and decreased osteoclast activity have been shown in
rats [16]. We have demonstrated that HFD can promote
inﬂammation of the bone microenvironment and negatively
inﬂuence bone remodeling toward osteoclastogenesis in mice
[17]. The diﬀerent reported eﬀects in these studies might be
due to diﬀerences in diet composition and animal models
used. Indeed, decreased bone resorption and bone formation
have been reported in patients with diabetes [18, 19] suggesting that both diet- and metabolic-related factors may diﬀerentially aﬀect the bone microenvironment. It has been
shown that knockdown of Nox2 can ameliorate the adipose
tissue inﬂammatory status in HDF mice [20, 21]. In addition,
inﬂammatory cytokines such as tumor necrosis factor alpha
(TNF-α) can activate Nox2 and increase its activity [22, 23].
Therefore, Nox2 and inﬂammation are directly interrelated
since enhanced inﬂammation in the bone microenvironment
can negatively aﬀect bone remodeling toward bone resorption. Therefore, we may assume that nox2 has a strong role
in obesity-mediated bone remodeling.
Oxidative stress is shown to be a key mediator of bone
loss [24, 25]. Elevated levels of reactive oxygen species
(ROS), speciﬁcally superoxide, are consistently associated
with increased osteoclastic activity in patients with bone
disorders [26, 27] such as bone loss observed in the elderly
population or patients with rheumatoid arthritis. The ageassociated decrease in sexual hormones in both men and
women is also an important risk factor for bone loss that
is related to a decrease in sexual hormones. Finally, it is
commonly observed that elderly osteoporotic patients are
deﬁcient in vitamins with antioxidant properties [27].
Whether the bone loss is due to a ROS overproduction
and/or to an antioxidant level reduction, the resulting oxidative stress plays an essential role in osteoporosis. Given
the complexity of the various sources of ROS in the bone
and the etiology of bone disorders, the identiﬁcation of the
source of ROS for each disease and the elucidation of the
mechanism by which ROS are produced and contribute are
essential to developing speciﬁc and eﬃcient therapy [25, 28].
NADPH oxidases (Nox) are considered key ROSgenerating enzymes, whose activity is essential for normal
cell function [29]. The Nox family encompass the gp91phox
(Nox2), Nox1, Nox3, Nox4, Nox5, Duox-1, and Duox-2. In
addition to Nox2, Nox1 and Nox4 are also known to be
expressed in the bone microenvironment [25]. However, in
this present work, we have mainly studied the role of Nox2
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in obesity-mediated bone remodeling using a Nox2knockout mouse model. In the bone microenvironment,
hematopoietic stem cells commit to bone resorbing osteoclastic lineage in response to the receptor activator of NFκB ligand (RANKL) which is produced by osteoblasts,
osteocytes, and bone marrow stromal cells [30]. The ligandmediated activation of the RANK receptor by RANKL triggers a Nox-derived ROS-dependent signaling cascade which
is crucial for osteoclast diﬀerentiation [31]. In particular,
Nox1 and Nox2 are reported to be implicated in osteoclast
diﬀerentiation in response to RANKL activation, while
Nox4 and Nox2 have been reported to contribute to the bone
resorption activity of mature osteoclasts [32–35]. By contrast,
whether Nox enzymes are involved in osteoblast diﬀerentiation and function is still under investigation [36, 37]. In this
context, some evidence suggests the implication of Nox4 in
osteoblast diﬀerentiation and that of Nox2 in osteoblast precursor cell proliferation [25]. However, these ﬁndings were
not conﬁrmed in vivo in knockout mice.
Studies investigating the role of oxidative stress in bone
diseases have been mainly performed by determining the eﬀect
of ROS overproduction on bone cell function and bone remodeling. It has been reported that ROS can promote bone loss by
lowering osteoblast diﬀerentiation and inducing their apoptosis while concomitantly stimulating RANKL-induced osteoclast formation [38]. In addition, an osteoclast-generated
superoxide increase is involved in bone matrix degradation
[39]. While we showed that the expression level of cathepsin
K, which is an indicator of bone resorption activity, is
increased by a HFD in a redox-dependent manner [40], the
exact role of Nox2 as a major source of ROS remains unknown.
In the present study, we focused upon investigating the
role of Nox2 in obesity-mediated inﬂammation-dependent
bone remodeling. Our results show that a HFD augments
bone marrow adipogenesis and osteoclastogenesis in a
Nox2-dependent manner.

2. Materials and Methods
2.1. Reagents and ELISA Kits. α-Modiﬁed minimal essential
medium (α-MEM), Roswell Park Memorial Institute (RPMI)
1640 medium, phenol red-free α-MEM, Hanks’ balanced salt
solution (HBSS), and fetal bovine serum were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Recombinant
mouse RANKL and M-CSF were obtained from PeproTech
Inc. (Rocky Hill, NJ) and R&D Systems (Minneapolis, MN,
USA), respectively. Phorbol 12-myristate 13-acetate (PMA)
and superoxide dismutase (SOD) were obtained from Sigma
Chemical (St. Louis, MO, USA). The enhancer-containing
luminol-based detection system (Diogenes) was obtained
from National Diagnostics (Atlanta, GA, USA). Experiments
were performed following our previously published procedures as reported in Halade et al. [17].
2.2. Animals and Diet. Six-week-old wild-type (WT) and
Nox2-knockout (KO) male mice were purchased from
Jackson Laboratories (Bar Harbor, Maine 04609, USA) and
provided water and standard American Institute of Nutrition
(AIN) 93G (a diet recommended by AIN for growth) ad
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libitum. At 8 weeks, age-matched animals were randomized
into two groups, each containing 10 mice. Subsequently, the
mice were housed in a standard controlled animal care
facility in cages (5 mice/cage) and fed with a high-fat diet
(Jackson lab. DIO diet 45% fat; HFD) or a standard diet
(SD) ad libitum for 3 months. National Institutes of Health
guidelines were strictly followed, and all the studies were
approved by the Institutional Laboratory Animal Care and
Use Committee of the University of Texas Health Science
Center (San Antonio, TX). Body weight was measured weekly.
After completion of the 5-month period, animals from both
experimental groups were sacriﬁced under isoﬂurane anesthesia. Experiments were performed following our previously published procedures as reported in Halade et al. [17].

crushed under liquid nitrogen conditions using a Kinematica
Tissue Pulverizer, and RNA was isolated using the RNeasy
Mini Kit following the manufacturer’s instructions (Qiagen,
Valencia, CA). Total RNA concentration was assessed in
NanoDrop™ 1000 spectrophotometer (Thermo Scientiﬁc,
Wilmington, DE, USA). mRNA expression of genes encoding IL-6, TNF-α, RANKL, cathepsin K (ctsk), runt-related
transcription factor 2 (RUNX2), peroxisome proliferatoractivated receptor (PPAR-γ), and 18S was measured by
real-time RT-PCR carried out using Taq polymerase and
SYBR green dye (Applied Biosystems, Foster City, CA) and
an ABI Prism 7900HT Sequence Detection System (Applied
Biosystems). mRNA Ct values for these genes were normalized to the housekeeping gene 18S.

2.3. Measurement of Bone Mineral Density (BMD). Mice were
anesthetized with ketamine/xylazine, and a dual-energy Xray absorptiometry (DXA) scan was performed as described
previously [41] before (mice aged 8 weeks) and after the
administration of the diet for 3 months (mice aged 20 weeks)
using a Lunar PIXImus mouse bone densitometer (General
Electric). BMD was analyzed manually with PIXImus software as described previously [41].

2.7. Measurement of Superoxide in Freshly Isolated BM Cells.
As previously reported, the rate of superoxide production by
BM cells was determined using a luminol-based chemiluminescent reagent (Diogenes, National Diagnostics, GA) that is
speciﬁc to superoxide [17, 44]. The cells were washed with
PBS and placed in Hanks’ balanced salt solution (HBSS).
For the assay, a 100 μl aliquot of the Diogenes reagent was
mixed with a maximum of 1 × 105 cells and incubated at
37°C for 2–4 minutes. Superoxide generation was stimulated
with PMA (50 ng/ml) in the presence or absence of SOD
(20 μg/ml). Chemiluminescence was measured every minute
for up to 60 minutes using a microplate reader (BioTek Clarity™, BioTek Instruments Inc., VT, USA) and an integration
time of 5 seconds.

2.4. Preparation and Culture of Primary Bone Marrow (BM)
Cells and Osteoclast Diﬀerentiation. At the conclusion of
the study, BM cells were isolated from the tibiae and femurs
of all groups of mice according to our previously described
methods [17, 42]. Brieﬂy, isolated BM cells were cultured in
α-MEM containing 10% heat-inactivated fetal calf serum
(FCS; Invitrogen), 100 U/ml penicillin G, and 100 μg/ml
streptomycin at 37°C for 2 h under 95% air and 5% HFD2.
Nonadherent cells were carefully harvested and centrifuged
at 2000 rpm for 5 min at room temperature, and viability
was determined using the trypan blue exclusion method.
They were subsequently cultured in α-MEM medium in
24-well (1 × 106 cells/well) clear-bottom white culture
plates, supplemented with or without 50 ng/ml RANKL and
20 ng/ml M-CSF. A half-volume of the medium, with or
without RANKL/M-CSF, was replaced with the fresh
medium every 3 days. At day 6, plates were ﬁxed and the
number of formed osteoclasts was determined by staining
cells with tartrate-resistant acid phosphatase (TRAP) using
a TRAP staining kit (Sigma, St. Louis, MO, USA). TRAPpositive multinucleated cells (MNCs) of more than three
nuclei were counted as osteoclasts under microscopic observation and expressed as a number of cells per ﬁeld.
2.5. Bone Histology. Left femur specimens from each group
were collected and trimmed of excess tissue and were ﬁxed
in 10% neutral buﬀer formalin (NBF) for 48 hours at room
temperature (RT). Bone specimens were decalciﬁed in 10%
EDTA in water for 2 weeks at RT and were then placed in
70% ETOH, processed and embedded in paraﬃn, and
stained with hematoxylin and eosin (H&E) as previously
described [17, 43].
2.6. Quantitative Real-Time Reverse Transcriptase PCR (RTPCR). Experiments were performed following our previously
published procedures [17]. Brieﬂy, right whole femurs were

2.8. Statistical Analysis. Data are presented as mean
values ± SEM of 3–4 experiments using 4–6 mice/group. The
statistical analysis employed for each experiment is reported
in the ﬁgure legends.

3. Results
3.1. ROS Production in Bone Marrow Cells Isolated from WT
and KO Mice. Superoxide production was examined in
freshly isolated bone marrow (BM) cells. A transient PMAinduced production of superoxide was observed in BM cells
derived from WT mice. The observed superoxide generation
reached its maximum in 5 minutes; then, it sustained up to
30 min and after that decreases to reach the nonstimulated
levels in 60 to 90 min. The PMA-elicited superoxide production of BM cells was not signiﬁcantly aﬀected by the HFD
(Figure 1). Abrogation of the chemiluminescence signals by
the addition of the superoxide inhibitor superoxide dismutase (SOD) indicated that superoxide anion was speciﬁcally
detected. As expected, BM cells isolated from KO mice were
unable to produce any detectable amount of superoxide.
These data indicated that a high-fat diet did not signiﬁcantly
alter superoxide production of BM cells and conﬁrmed the
phenotype of Nox2-knockout mice.
3.2. Eﬀect of Nox2 on HFD Alteration of Bone Mineral
Density (BMD). Three months of feeding of a HFD signiﬁcantly increased body weight and fat mass of both WT and
KO mice. There was no signiﬁcant diﬀerence in body weights
(BW) and total fat mass (FM) between SD WT and SD KO
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Figure 1: The high-fat diet does not alter superoxide production by the bone marrow cells. Superoxide production was measured using bone
marrow (BM) cells isolated from wild-type and Nox2-knockout mice fed with either a standard (SD) or a high-fat diet (HFD) for 3 months.
BM cells were stimulated with 50 ng/ml PMA, and chemiluminescence was monitored for the indicated time (a). After normalization by
subtraction of the zero time value of the chemiluminescence output, the area under the curve was calculated as a measure of total
superoxide production (b). Data are expressed as mean ± SEM (n = 4, 6 mice/group). Two-way ANOVA followed by post hoc Tukey’s
multiple comparison test was used to assess diﬀerences among groups with signiﬁcance deﬁned as P < 0 05. ∗ Signiﬁcantly diﬀerent from
SD-WT. #Signiﬁcantly diﬀerent from HDF-WT.

mice (26.8 ± 0.44 g BW and 3.8 + 0.42 g total fat mass and
23.7 ± 1.5 g BW and 3.3 ± 0.24 g FM, respectively) and
between HFD WT and HFD KO mice (41.3 ± 1.68 g BW
and 8.6 ± 1.7 g FM and 36.3 ± 2.46 g BW and 9.9 + 2.3 g FM,
respectively). We measured the bone mineral density of all
four groups once before starting the experimental diets and
again just before sacriﬁce. Bone mineral density was not
signiﬁcantly reduced in WT versus KO mice fed with a
SD with the exception of the distal femoral metaphysis
bone “section” (Figure 2(a)). An increase in bone mineral
density was observed in both WT and KO animals in all
bone sections except distal femoral metaphysis of HDF
mice in comparison to that of SD mice (Figure 2(a)). However, the magnitude of this eﬀect was signiﬁcantly greater in
KO mice as compared to WT mice as indicated by the data
in Figure 2(b) reporting the percentage change of the diﬀerence between HDF and SD. Indeed, this ﬁgure clearly
depicts that the diﬀerences in BMD between HFD- and
SD-fed mice (Figure 2(a)) were signiﬁcantly higher in KO
mice as compared to WT mice indicating that HFDinduced BMD alteration depends on Nox2.
3.3. Nox2 Mediates HFD-Induced Bone Marrow Adiposity.
Alteration of bone mineral density by a HFD is generally
paralleled by enhanced bone marrow adiposity. We therefore
asked whether Nox2 downregulation could aﬀect bone marrow adiposity. Our results indicate that the HFD increased
the number of adipocytes. Interestingly, this eﬀect was
dramatically reduced in KO mice (Figure 3(a)). In addition, we found that the expression level of PPAR-γ, a
known marker of adipocyte diﬀerentiation and maturation,
was increased in the bone of WT HFD mice as compared

to WT SD mice (Figure 3(b)), and this eﬀect was abrogated in KO mice. Since the same progenitor cells lead
to the formation of osteoblasts and adipocytes, we measured the Runx2 expression level, a known marker of osteoblastogenesis. Interestingly, HFD signiﬁcantly increased the
osteoblastogenic factor Runx2 in both WT and KO mice.
These data suggest that Nox2 regulates only bone marrow
adiposity and does not alter osteoblastogenesis.
3.4. Nox2 Mediates HFD-Induced Osteoclastogenesis. Herein,
we wanted to investigate the potential involvement of Nox2
in osteoclastogenesis. To this end, in vitro osteoclastogenesis
was induced in BM cells isolated from all the experimental
groups by stimulation with RANKL and MCSF. Our data
indicated that BM cells from WT HFD mice formed a signiﬁcantly higher number of TRAP-positive osteoclast-like
cells as compared to BM cells isolated from WT SD mice
(Figure 4(a)). Interestingly, this HFD-associated eﬀect was
signiﬁcantly reduced when BM cells isolated from KO animals were employed, suggesting the involvement of Nox2
in HFD-induced osteoclastogenesis (Figure 4(a)). These
observations are in agreement with the ﬁnding that proinﬂammatory and proosteoclastogenic factors such as TNF-α,
IL-6, RANKL, and CTSK mRNA levels were signiﬁcantly
increased in the bones of WT HFD mice but not in those
of KO HFD mice (Figure 4(b)). These data support the
hypothesis that Nox2 is implicated in the increased bone
resorption associated with HFD. More importantly, its
absence protects the mice against the Nox2-dependent deleterious eﬀect elicited by HFD on the bone. Our data suggest
that HFD-induced Nox2-dependent bone deterioration is
associated with enhanced osteoclastogenesis.

Oxidative Medicine and Cellular Longevity

30

#

0

Tibial diaphysis

KO-SD

KO-HFD

40
⁎
% difference

30

10
0

Femoral diaphysis

40

20
10

30
20
10
KO-HFD

KO-SD

WT-SD

KO-SD

WT-SD

KO-HFD

0
WT-HFD

0

⁎

WT-HFD

% difference

WT-HFD

−10

WT-SD

−5

20

KO-HFD

5

KO-SD

% difference

% difference

10

Proximal tibial metaphysis
§

WT-HFD

Distal femoral metaphysis
⁎

WT-SD

15

5

(a)

Distal femoral metaphysis

20

⁎

20

% difference

10
0
−10

15
10
5

Femoral diaphysis

25

⁎
% difference

20
15
10
5

KO HFD-SD

WT-HFD-SD

KO HFD-SD

WT-HFD-SD
% difference

⁎

0

−20

25

Proximal tibial metaphysis

Tibial diaphysis
⁎

20
15
10
5
0
WT-HFD-SD

KO HFD-SD

WT-HFD-SD

0

KO HFD-SD

% difference

30

(b)

Figure 2: Eﬀect of Nox2 on high-fat-diet- (HFD-) induced changes in bone mineral density (BMD). Eight-week-old WT and Nox2-KO mice
were fed with either a standard lab chow diet (SD) or HFD for 3 months. Mice were scanned with dual-energy X-ray absorptiometry (DXA)
before and after administration of experimental diets. (a) Percent changes in BMD before and after experimental diets in diﬀerent bone
regions. (b) Percentage change of the BMD diﬀerence between mice fed with an SD and an HFD in diﬀerent bone regions. Data are
expressed as mean ± SEM (n = 3, 4 mice/group). In (a), two-way ANOVA followed by post hoc Tukey’s multiple comparison test was used
to assess diﬀerences among groups with signiﬁcance deﬁned as P < 0 05. #Signiﬁcantly diﬀerent from all the group data in the graph.
§
Signiﬁcantly diﬀerent from all the group data in the graph. ∗ Signiﬁcantly diﬀerent from SD-KO in all the graphs. In (b), unpaired t-test
with Welch’s correction has been used to assess signiﬁcance between the groups with signiﬁcance deﬁned as P < 0 05. ∗ Signiﬁcantly
diﬀerent from each other in all the graph data.
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Figure 3: Eﬀect of Nox2 on high-fat-diet- (HFD-) induced changes in bone marrow adiposity. Eight-week-old WT and Nox2-KO mice were
fed with either an SD or an HFD for 3 months. (a) Left femurs were collected after sacriﬁce and ﬁxed in 10% neutral-buﬀered saline (NBF).
After processing, sections of bone were embedded in paraﬃn and stained with hematoxylin and eosin (H&E). Representative
microphotographs of stained femur sections from each group are shown. Magniﬁcation ×100. The arrow shows adipocytes in the bone
marrow cavity. Analysis of white areas (adipocytes) inside the bone marrow has been performed using NIH ImageJ software. (b) Right
femurs were crushed under liquid nitrogen, and RNA was isolated and analyzed for mRNA levels for Runx2 and PPAR-γ by real-time
RT-PCR. mRNA Ct values for these genes were normalized to the housekeeping gene 18S. Data are expressed as mean ± SEM (n = 3, 4
mice/group). Two-way ANOVA followed by post hoc Tukey’s multiple comparison test was used to assess diﬀerences among groups
with signiﬁcance deﬁned as P < 0 05. §Signiﬁcantly diﬀerent from SD-WT. #Signiﬁcantly diﬀerent from HFD-WT. ∗ Signiﬁcantly
diﬀerent from SD-KO.

4. Discussion
Using a corn oil diet in 12-month-old female mice, we
previously reported that obesity increased osteoclast formation and lowered osteoblast formation directing the
overall bone homeostasis toward bone resorption [17]. In
the present work, our results indicate that obesity-mediated
bone remodeling in favor of osteoclastogenesis can occur
independently from either the aging process or the gender
type [17, 45–47]. Our data demonstrated that the magnitude
of the increase in BMD was signiﬁcantly greater in KO mice
as compared to WT mice suggesting Nox2 implication in
HFD-induced bone alteration.
While the alteration in BMD measured in growing mice
cannot be considered bone loss, our data revealed that the
HDF-induced bone remodeling occurred in a Nox2dependent manner. We found that a HFD was able to
increase both the number of adipose cells and the expression
of PPAR-γ in the bone marrow. Interestingly, these HFDassociated eﬀects were signiﬁcantly reduced in KO mice
while body weight and fat mass gain were similar to those
observed in wild-type mice. This observation supports the
idea that more than body weight or fat mass, the localization
of fat cell accumulation is primordial in contributing to tissue
lipotoxicity [48–50].
Both adipocytes and osteoblasts are generated from mesenchymal stem cells. Therefore, it has been proposed that a
HFD can alter bone marrow cellular composition resulting
in an increased adipocyte number and decreased osteoblasts.
This imbalanced bone marrow composition would decrease
osteogenesis [7], thus reducing BMD and bone mass. Our

data indicate that HFD was able to increase Runx2, suggesting that osteoblastogenesis is not reduced, but on the contrary increased by this feeding regime. We think that this
could be a primary adaptive mechanism to maintain bone
integrity when there is an increase in the total body weight.
Indeed, this is in accord with the increase in bone mineral
density we observe in HFD mice (Figure 2). More importantly, we observed that only the formation of bone marrow
adipocytes was aﬀected in Nox2-knockout mice. Also, the
Nox2-dependent alteration of BMD could not be attributed
to osteoblastogenesis dysregulation. Since adipocytes secrete
proinﬂammatory cytokines favoring osteoclast formation
[40], we examined whether a HFD could aﬀect osteoclastogenesis. Our result highlighted that the expression of proinﬂammatory and proosteoclastogenic factors such as TNF-α,
IL-6, RANKL, and CTSK was signiﬁcantly increased in the
bones of WT HFD mice as compared to KO mice.
We also analyzed the formation of osteoclasts in vitro
using mouse-derived BM cells. RANKL activation is a pivotal
step toward mature osteoclast diﬀerentiation [51, 52]. Importantly, NADPH oxidase-mediated superoxide production
has been reported to execute a key role in osteoclastogenesis
[33], and RANKL is known to stimulate ROS production
[32]. Given their macrophage nature, all forms of osteoclasts
express high amounts of Nox2 at both the protein and
mRNA levels [32–34, 53]. However, osteoclasts also express
Nox4 in their mature form and Nox1 in undiﬀerentiated
and diﬀerentiated preosteoclastic BM cells [35, 54]. Our data
indicate that Nox2 is a major producer of ROS by BM cells
and that it contributes to RANKL-mediated osteoclast formation in vitro. Interestingly, Nox1 was also shown to be
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Figure 4: Eﬀect of Nox2 on high-fat-diet- (HFD-) induced changes in bone marrow osteoclastogenesis. Eight-week-old WT and Nox2-KO
mice were fed with an SD or an HFD for 3 months. (a) Bone marrow cells were isolated from the left femur and tibia of each group. Bone
marrow cells (1 × 106) were cultured in the presence of RANKL and MCSF for 5 days. Cells were then stained for TRAP and counted
under a microscope. TRAP-positive multinucleated cells (MNCs) containing more than 3 nuclei were considered osteoclasts. Bars show
the number of TRAP-positive MNCs in each group expressed as a number of cells per ﬁeld. (b) Right femurs were crushed under liquid
nitrogen, and RNA was isolated and analyzed for mRNA levels for TNF-α, IL-6, RANKL, and cathepsin K (CTSK) by qRT-PCR. mRNA
Ct values for these genes were normalized to the housekeeping gene 18S. Data are expressed as mean ± SEM (n = 4, 5 mice/group). Twoway ANOVA followed by post hoc Tukey’s multiple comparison test was used to assess diﬀerences among groups with signiﬁcance
deﬁned as P < 0 05. §Signiﬁcantly diﬀerent from WT-SD. #Signiﬁcantly diﬀerent from WT-HFD. ∗ Signiﬁcantly diﬀerent from SD-KO.

essential in osteoclast diﬀerentiation stimulated by RANKL
[32]. In this study, Nox1 silencing signiﬁcantly reduced
ROS production and diﬀerentiation induced by RANKL.
Given that ROS are shown to be a key intermediate in osteoclastogenesis [55], this ﬁnding is surprising because not only
is Nox2 highly expressed in BM cells but also its activation
generates a far greater amount of ROS. The explanation for
these discrepancies might relate to the possibility that Nox1
siRNA altered the expression of Nox2. In this regard, it has
been reported that increased expression of diﬀerent Nox
enzymes may compensate the loss of particular isoforms in

osteoclasts [32, 56, 57]. Furthermore, other studies suggest
that Nox1 and Nox2 might compensate for one another for
RANKL-mediated stimulation of osteoclast formation [33].
Finally, recent works demonstrate that Nox4 expression is
increased in Nox2-deﬁcient osteoclasts and contributes to
osteoclast formation [35, 54]. In accord with these in vitro
studies, the absence of evident bone abnormality in Nox1-,
Nox2-, and Nox4-deﬁcient mice suggests that the genome
redundancy can guarantee the ROS production that is necessary to maintain bone growth and homeostasis. In our study,
we did not observe any signiﬁcant eﬀect of either the diet or
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the genotype on Nox1 and Nox4 mRNA expression levels
(data not shown), suggesting that the eﬀects observed in
KO mice could reasonably be attributed to Nox2 deﬁciency.
In the present work, we observed that despite any gross
alteration of the bone structure, WT KO mice tend to be
smaller, and we observed an overall downregulation of genes
controlling the bone environment (adiposity, osteoblast,
osteoclast, and inﬂammation). However, our data reveal that
under a pathological condition (i.e., HFD), Nox2 deﬁciency
had a beneﬁcial eﬀect on bone. Nox2 deﬁciency counteracted
HFD-induced bone marrow adiposity and osteoclastogenesis. Also, it is possible that the relevance and implication of
each Nox enzyme in osteoclast formation and activity might
be revealed only under a pathological or stress condition.
To our knowledge, the data reported in this study provide
the ﬁrst evidence that Nox2 mediates HFD-induced bone
marrow adiposity and osteoclastogenesis without aﬀecting
osteoblastogenesis, therefore aﬀecting bone homeostasis in
favor of bone resorption.
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